Prednisolone Rhinosinusitis Efficacy Trial (PRET) study - PRET study
Active, not recruiting
- Conditions
- patients (> 18 years) with rhinosinusitis-like symptoms lasting for at least 5 days.MedDRA version: 9.1Level: LLTClassification code 10052106Term: Rhinosinusitis
- Registration Number
- EUCTR2008-000560-17-NL
- Lead Sponsor
- MC Utrecht, Julius Center for Health Sciences and Primary Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with RS - according to the criteria of the guidelines of the Dutch College of General Practitioners - for at least 5 days
Age > 18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Fever > 38.5°C (measured by GP)
> 2 episodes of RS in the previous 12 months
Use of either nasal or oral corticosteroids in the previous 4 weeks
Contraindication for prednisolone treatment
Pregnancy
Previous ENT surgery for malignant disease
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method